会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • IMPROVED CELL-BASED FLUORESCENT ASSAYS FOR IDENTIFYING ALPHA AND DELTA ENaC MODULATORS
    • 改进的基于细胞的荧光分析用于鉴定ALPHA和DELTA ENaC调节子
    • WO2008013969A2
    • 2008-01-31
    • PCT/US2007/016963
    • 2007-07-30
    • SENOMYX, INC.SERVANT, GuyBRUST, PaulRAY, SumitaHUNG, Ning
    • SERVANT, GuyBRUST, PaulRAY, SumitaHUNG, Ning
    • G01N33/53
    • G01N33/6872G01N33/5008G01N33/566
    • This invention relates to improved electrophysiological assays that measure sodium conductance activity of a delta or alpha human epithelial sodium channel (ENaC) expressed in a test cell in the presence and absence of delta hENaC enhancers. The improvement comprises contacting the test cells with an amount of sodium ion, typically from at least 15 mM to 140 mM, for a time sufficient, e.g. for at least 5 minutes to an hour, prior to the test cells being screened against at least one putative enhancer. It has been surprisingly discovered that this sodium pretreatment enhances assay sensitivity, especially assays that use membrane potential or ion sensitive dyes that detect changes in conductance fluorimetrically. These enhancer compounds have potential application in modulating (enhancing) salty taste perception and for treating disorders involving aberrant hENaC function.
    • 本发明涉及改进的电生理测定,其测量在δHENaC增强子存在和不存在下在测试细胞中表达的δ或α人类上皮钠通道(ENaC)的钠电导活性。 改进包括使测试细胞与一定量的钠离子接触,所述钠离子量通常为至少15mM至140mM,持续足够的时间, 至少5分钟至1小时,在测试细胞针对至少一个推定的增强子进行筛选之前。 令人惊讶地发现,这种钠预处理增强了测定灵敏度,尤其是使用膜电位的测定法或荧光测定法检测电导变化的离子敏感染料。 这些增强剂化合物可用于调节(增强)咸味感觉和治疗涉及异常hENaC功能的疾病。
    • 6. 发明申请
    • ASSAYS FOR IDENTIFYING GENES ENCODING SALTY TASTE RECEPTORS AND MODULATORS
    • 用于鉴定编码盐味受体和调节剂的基因的测定
    • WO2010065863A2
    • 2010-06-10
    • PCT/US2009/066788
    • 2009-12-04
    • SENOMYX, INC.MOYER, BryanZLOTNIK, AlbertHEVEZI, PeterSOTO, HortensiaLU, MinGAO, NaSAGANICH, MichaelDAHAN, MichaelLAITA, BiancaSERVANT, GuyBRUST, PaulWILLIAMS, Mark
    • MOYER, BryanZLOTNIK, AlbertHEVEZI, PeterSOTO, HortensiaLU, MinGAO, NaSAGANICH, MichaelDAHAN, MichaelLAITA, BiancaSERVANT, GuyBRUST, PaulWILLIAMS, Mark
    • A01K67/00C12Q1/68C12Q1/02C12N5/10C12N1/00
    • G01N33/5008A01K2267/03C07K14/705G01N2333/705
    • The present invention relates to rationales for selecting salty taste receptors from a discrete set of taste specific genes disclosed infra by use of methods including electrophysiology, bioiirformatics, and quantitative gene expression assays using transgenic animals as well as functional assays wherein these salty taste receptors may be expressed alone or in association with other taste specific polypeptides such as TRPML3, PKD2L1 or GPRl 13. In addition the invention relates to the use of the identified salty taste receptors in assays, preferably high- throughput, in order to identify modulators which maybe used as flavor additives to modulate salty taste. Preferably, the invention provides high- throughput mammalian and medium- throughput oocyte- based electrophysiological assays for identifying human TRPML3 modulators, preferably TRPML3 enhancers. Compounds that modulate TRPML3 function in the assay are expected to affect salty taste in humans. The inventive electrophysiological assays, such as the two-electrode voltage-clamp technique, facilitate the identification of compounds which specifically modulate human TRPML3. The assays of the invention provide a robust screen useful to detect compounds that facilitate (enhance) or inhibit TRPML3 function. Compounds that enhance or block TRPML3 channel activity should thereby modulate salty taste. In addition, these compounds maybe used to regulate sodium excretion, urinary output and other biological functions relating to sodium levels. This invention relates to the elucidation that TRPML3 is involved in salty taste perception in primates including humans and likely other mammals (given the significance of sodium and other ions to physiological functions and conditions this phenotype is likely strongly conserved in different animals). The TRPML3 gene also modulates one or more of sodium metabolism, sodium excretion, blood pressure, fluid retention, cardiac function and urinary functions such as urine production and excretion.
    • 本发明涉及通过使用包括电生理学,生物信息学和使用转基因动物的定量基因表达测定法的方法从下文公开的一组离体味觉特异性基因中选择咸味受体的基本原理以及功能 其中这些咸味受体可以单独表达或与其他味道特异性多肽例如TRPML3,PKD2L1或GPR113结合表达。另外,本发明涉及鉴定的咸味受体在测定中的用途,优选高通量 为了鉴定可能用作香料添加剂来调节咸味的调节剂。 优选地,本发明提供了用于鉴定人TRPML3调节剂,优选TRPML3增强子的高通量哺乳动物和中等通量的基于卵母细胞的电生理学测定法。 期望在测定中调节TRPML3功能的化合物影响人类的咸味。 本发明的电生理学测定法,例如双电极电压钳技术有助于鉴定特异性调节人TRPML3的化​​合物。 本发明的测定法提供了用于检测促进(增强)或抑制TRPML3功能的化合物的有力筛选。 因此增强或阻断TRPML3通道活性的化合物应调节咸味。 此外,这些化合物可用于调节钠排泄,尿量和与钠水平有关的其他生物学功能。 本发明涉及说明TRPML3参与包括人类和可能的其他哺乳动物(考虑到钠和其它离子对生理功能和条件的重要性,这种表型在不同动物中强烈保守)的灵长类中的咸味感知。 TRPML3基因还调节钠代谢,钠排泄,血压,体液潴留,心脏功能和泌尿功能如尿液产生和排泄中的一种或多种。
    • 7. 发明申请
    • FUNCTIONAL COUPLING OF T1RS AND T2RS BY GI PROTEINS, AND CELL-BASED ASSAYS FOR THE IDENTIFICATION OF T1R AND T2R MODULATORS
    • 通过GI蛋白的T1RS和T2RS的功能性联合,以及用于鉴定T1R和T2R调节剂的基于细胞的测定
    • WO2004069191A2
    • 2004-08-19
    • PCT/US2004/002987
    • 2004-02-03
    • SENOMYX INC.SERVANT, GuyOZECK, MarkBRUST, PaulXU, Hong
    • SERVANT, GuyOZECK, MarkBRUST, PaulXU, Hong
    • A61K
    • G01N33/5041G01N33/5008G01N33/566G01N2333/726G01N2500/10
    • The invention resides in part in the discovery that G proteins other than Gα 15 couples to T1R and T2R taste receptors, particularly G i proteins such as G αi . Related to this discovery, the invention provides cell-based assay methods for identifying compounds that modulate the activity of specific T1R or T2R taste receptors or which modulate the effect of other T1R or T2R modulators on T1R or T2R activity. These assay methods preferably detect the effect of a putative T1R or T2R modulator compound on MAPK activation, cAMP accumulation, or adenylyl cyclase activity or another signaling pathway regulated by G i proteins. The level of MAPK activation, cAMP accumulation or adenylyl cyclase is preferably determined by immunoassay methods that use ligands (monoclonal or polyclonal antibodies) that specifically bind an activated (phosphorylated) MAPK, cAMP, or adenylyl cyclase.
    • 本发明部分在于发现除了Galpha15之外的G蛋白与T1R和T2R味觉受体特别是Gi蛋白如Galphai偶联。 与这一发现有关,本发明提供基于细胞的测定方法,用于鉴定调节特异性T1R或T2R味觉受体的活性或调节其他T1R或T2R调节剂对T1R或T2R活性的影响的化合物。 这些测定方法优选检测推定的T1R或T2R调节剂化合物对MAPK激活,cAMP积聚或腺苷酸环化酶活性或由Gi蛋白调节的另一信号传导途径的影响。 MAPK活化水平,cAMP积聚或腺苷酸环化酶优选通过使用特异性结合活化(磷酸化)MAPK,cAMP或腺苷酸环化酶的配体(单克隆或多克隆抗体)的免疫测定方法来确定。
    • 9. 发明申请
    • IDENTIFICATION OF TRPML3 (MCOLN3) AS A SALTY TASTE RECEPTOR AND USE IN ASSAYS FOR IDENTIFYING TASTE (SALTY) MODULATORS AND/OR THERAPEUTICS THAT MODULATE SODIUM TRANSPORT, ABSORPTION OR EXCRETION AND/OR ALDOSTERONE AND/OR VASOPRESSIN PRODUCTION OR RELEASE
    • 鉴定作为盐酸受体的TRPML3(MCOLN3)和用于鉴定调节运输,吸收或/或阿尔斯酮和/或维生素C生产或替代物的硫酸盐(SALTY)调节剂和/或治疗剂的测定中的用途
    • WO2009008950A2
    • 2009-01-15
    • PCT/US2008/007101
    • 2008-06-06
    • SENOMYX, INC.MOYER, BryanZLOTNIK, AlbertHEVEZI, PeterSOTO, HortensiaLU, MinGAO, NaSERVANT, GuyBRUST, PaulWILLIAMS, MarkKALABAT, DaliaWHITE, Evan, Carl
    • MOYER, BryanZLOTNIK, AlbertHEVEZI, PeterSOTO, HortensiaLU, MinGAO, NaSERVANT, GuyBRUST, PaulWILLIAMS, MarkKALABAT, DaliaWHITE, Evan, Carl
    • C40B30/04C12N5/10C12Q1/68
    • C12Q1/6883C12Q2600/136C12Q2600/158C40B30/04C40B40/10G01N33/5044G01N33/566G01N33/6872G01N2333/726G01N2500/10
    • The present invention relates to high-throughput mammalian and medium-throughput oocyte-based electrophysiological assays for identifying human TRPML3 modulators, preferably TRPML3 enhancers. Compounds that modulate TRPML3 function in the assay are expected to affect salty taste in humans. The inventive electrophysiological assays, such as the two-electrode voltage-clamp technique, facilitate the identification of compounds which specifically modulate human TRPML3. The assays of the invention provide a robust screen useful to detect compounds that facilitate (enhance) or inhibit TRPML3 function. Compounds that enhance or block TRPML3 channel activity should thereby modulate salty taste. In addition, these compounds may be used to regulate sodium excretion, urinary output and other biological functions relating to sodium levels. This invention relates to the elucidation that TRPML3 is involved in salty taste perception in primates including humans and likely other mammals (given the significance of sodium and other ions to physiological functions and conditions this phenotype is likely strongly conserved in different animals). The TRPML3 gene also modulates one or more of sodium metabolism, sodium excretion, blood pressure, fluid retention, cardiac function and urinary functions such as urine production and excretion. The inventors have identified TRPML3 as encoding a salty taste receptor in primates and humans (and likely other mammals) based on gene expression assays which have determined that TRPML3 is expressed specifically in taste bud cells and not in lingual epithelial cells, similar assays that have determined that TRPML3 is specifically expressed or enriched in the top half of taste bud cells in a subset of taste cells which do not express TRPM5 or PKD2L1, prior reports that document the expression of TRPML3 in other sensory organs such as the ear (therefore further substantiating the role of TRPML3 as a "professional" sensory gene), the strong expression of TRPML3 in the adrenal glands which play a strong role in regulation of sodium metabolism (as they regulate aldosterone a key molecule in sodium metabolism), and related thereto the fact that an autoimmune disease that elicits strong salt cravings, Addison's disease, involves destruction of the adrenal glands, and functional (electrophysiological) studies which indicate that TRPML3 conducts sodium and exhibits biochemical characteristics consistent with a human salty taste receptor (passes K+, Li+, and is amiloride-insensitive.) This application also discloses novel rationales and methods for identifying primate taste-specific genes, including genes involved in salty taste perception, especially human salty taste perception, as well as genes involved in sweet, bitter, umami, and sour taste and other taste perceptions including fat taste, and genes involved in other taste cell or taste receptor related activities such as digestive function and digestive related diseases, taste cell turnover, immunoregulation of the oral and digestive tract, and metabolic regulation such as in diabetes and obesity. The genes identified using these methods, can be used in assays for identifying taste modulators (enhancers or blockers) and potential t
    • 本发明涉及用于鉴定人TRPML3调节剂(优选TRPML3增强子)的高通量哺乳动物和中等吞吐量的基于卵母细胞的电生理测定法。 在测定中调节TRPML3功能的化合物预期会影响人体的咸味。 本发明的电生理测定,例如双电极电压钳技术,有助于鉴定特异性调节人TRPML3的化​​合物。 本发明的测定法提供了一种可用于检测促进(增强)或抑制TRPML3功能的化合物的稳健筛选。 增强或阻断TRPML3通道活性的化合物应该调节咸味。 此外,这些化合物可用于调节与钠水平相关的钠排泄,泌尿生产和其他生物功能。 本发明涉及TRPML3涉及包括人和可能的其他哺乳动物在内的灵长类动物的咸味感知(给出钠和其它离子对生理功能和条件的重要性,该表型可能在不同动物中强烈保守)。 TRPML3基因还调节钠代谢,钠排泄,血压,流体保留,心脏功能和尿液功能如尿液产生和排泄中的一种或多种。 发明人已经基于基因表达测定法将TrPML3鉴定为在灵长类动物和人类(以及可能的其他哺乳动物)中编码咸味受体,其已经确定TRPML3特异性地在味蕾细胞中表达,而不是在舌上皮细胞中表达, TRPML3在不表达TRPM5或PKD2L1的味觉细胞的子集中的特定表达或富集的上半部分的浓度中,先前报道了TRPML3在其他感觉器官如耳朵中的表达(因此进一步证实了 TRPML3作为“专业”感觉基因的作用),TRPML3在钠代谢调节中起重要作用的肾上腺中的强烈表达(因为它们调节醛固酮是钠代谢中的关键分子),与此相关的事实是 引起强烈渴望的自身免疫性疾病艾迪生病涉及肾上腺的破坏和功能性(电极 这些研究表明TRPML3可以进行钠化,并具有与人类咸味受体一致的生物化学特性(通过K +,Li +,而且是阿米洛利不敏感的)。本申请还公开了识别灵长类动物特异性基因的新理论和方法,包括 涉及咸味感知的基因,特别是人类咸味感知,以及涉及甜味,苦味,鲜味和酸味以及其它味道感觉(包括脂肪味道)的基因,以及涉及其它味觉细胞或味觉受体相关活性的基因,例如 消化功能和消化相关疾病,滋味细胞周转,口服和消化道的免疫调节,以及糖尿病和肥胖等代谢调节。 使用这些方法鉴定的基因可用于鉴定味觉调节剂(增强子或阻断剂)和潜在t的测定
    • 10. 发明申请
    • NOVEL CELL-BASED ASSAYS FOR INDENTIFYING ENHANCERS OR INHIBITORS OF T1R TASTE RECEPTORS (T1R2/T1R3 SWEET) AND UMAMI (T1R1/T1R3 UMAMI) TASTE RECEPTORS
    • 用于补充T1R TASTE受体(T1R2 / T1R3 SWEET)和UMAMI(T1R1 / T1R3 UMAMI)药物受体的增强剂或抑制剂的新基于细胞的测定
    • WO2008153881A1
    • 2008-12-18
    • PCT/US2008/007035
    • 2008-06-04
    • SENOMYX, INC.SERVANT, GuyKAMDAR, PoonitRIVADENEYRA, Adam
    • SERVANT, GuyKAMDAR, PoonitRIVADENEYRA, Adam
    • A61K39/395
    • G01N33/5008G01N2333/726
    • Improved assays for identifying modulators of sweet (TIR2/TIR3) and umami (TIRI/TIR3) taste receptors are disclosed These receptors may be the endogenous TIRs or may be functional variants such as chimeric taste receptors from the extracellular portion of one TIR or a variant or fragment thereof, and the transmembrane portion of another TIR or a variant or fragment thereof, preferably associated with a TIR3 polypeptide and a suitable G protein. The assays preferably use endogenous taste or gastrointestinal cells from mammalian cells or Xenopus oocytes which express TIR taste receptors or recombinant cell which express such TIRs. The modulators identified according to the assays are useful as taste modulators (which is confirmed in taste tests) and/or as therapeutics for treating conditions such as diabetes, obesity weight control, fat metabolism, glucose metabolism, insulin metabolism, satiety and/or the release of satiety peptides such as GLP-1.
    • 公开了用于鉴定甜味(TIR2 / TIR3)和鲜味(TIRI / TIR3)味觉感受器的调节剂的改进的测定法。这些受体可以是内源性TIR,或者可以是功能性变体,例如来自一个TIR或变体的胞外部分的嵌合味觉受体 或其片段,以及另一TIR或其变体或片段的跨膜部分,优选与TIR3多肽和合适的G蛋白相关联。 测定优选使用表达TIR味觉受体的哺乳动物细胞或非洲爪蟾卵母细胞的内源性味道或胃肠细胞或表达这种TIR的重组细胞。 根据测定法鉴定的调节剂可用作味觉调节剂(其在味觉测试中被证实)和/或用作治疗诸如糖尿病,肥胖体重控制,脂肪代谢,葡萄糖代谢,胰岛素代谢,饱腹感和/或 释放饱和肽如GLP-1。